Optimizing Enrollment and Decision-Making in a Complex Glioblastoma Dose-Escalation Trial
Shreya Yeramilli
By Titia Tjeenk Willink, MSc, Senior Project Director, Global Project Leadership at Allucent Study Background: Allucent was selected to perform a Phase I/II study in participants with glioblastoma for an emerging European biotech. Collaboration started early 2018 and FPI was enrolled later that year. Challenges Faced: Managing Cohort Logistics and Operational Barriers in a Complex Dose-Escalation Design One of the primary […] The post Optimizing Enrollment and Decision-Making in a Complex Gli